No abstract available
Publication types
-
Practice Guideline
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Alcohol Drinking / adverse effects
-
Bariatric Surgery
-
Biopsy
-
Child
-
Disease Management
-
Fatty Liver / diagnosis*
-
Fatty Liver / epidemiology
-
Fatty Liver / etiology
-
Fatty Liver / physiopathology
-
Fatty Liver / therapy*
-
Fatty Liver, Alcoholic / diagnosis
-
Fatty Liver, Alcoholic / therapy
-
Humans
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / administration & dosage
-
Hypoglycemic Agents / administration & dosage
-
Incidence
-
Liver Cirrhosis / diagnosis
-
Liver Cirrhosis / therapy
-
Mass Screening
-
Non-alcoholic Fatty Liver Disease
-
Prevalence
-
Risk Factors
-
Risk Reduction Behavior
-
Severity of Illness Index
-
United States / epidemiology
-
Vitamin E / administration & dosage
-
Weight Loss
Substances
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors
-
Hypoglycemic Agents
-
Vitamin E